Jennifer Zibuda

Jennifer Zibuda is an experienced professional in investor relations and corporate communications, currently serving as the Senior Director of Investor Relations at Vaxcyte since January 2023. Prior roles include Director of Investor Relations & Communications at Prothena Corporation plc and Associate Director of Investor Relations at Portola Pharmaceuticals, where additional responsibilities included Interim Head of Corporate Communications/Investor Relations. Jennifer has also held various positions at Alkermes, The Navigators Group, Inc., Scottwood Capital Management, Shumway Capital Partners, Camuto Group, The Stonington Institute, and the Women's Center of Southeastern CT. Jennifer holds a Master's Degree in Corporate Communication and Public Relations from Sacred Heart University and a Bachelor of Arts Degree in Psychology from the University of Connecticut.